Obesity & Overweight study: Hydration Plus
Official title Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy
ClinicalTrials.gov ID: NCT07641361
What this study is testing
- What it's testing
- The study wants to see if drinking more fluids can make side effects from GLP‑1 receptor agonist therapy less severe and help people stay on the medicine.
- Who it's for
- Adults who are overweight or have type 2 diabetes and are beginning treatment with a GLP‑1 receptor agonist.
- What's involved
- Participants will follow a hydration plan, attend study visits, give blood or urine samples, and report any side effects they experience.
- Time commitment
- The trial lasts about 17 weeks total, with a one‑week run‑in and 16 weeks of the hydration program, including regular study visits.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- Adults aged 18-60
- Recently prescribed a GLP-1RA (within one week of prescription)
- Fluent in English
- Willing to complete the study protocol
You likely can't join if
- Children and adults \> 60 years of age
- Those not taking a GLP-1RA
- Those who have been on a GLP-1RA longer than one week
- Not fluent in English
- Those who are pregnant or planning on becoming pregnant during the duration of the study
- Unwilling to comply with study protocol
See the full eligibility criteria
- Adults aged 18-60
- Recently prescribed a GLP-1RA (within one week of prescription)
- Fluent in English
- Willing to complete the study protocol
- Children and adults \> 60 years of age
- Those not taking a GLP-1RA
- Those who have been on a GLP-1RA longer than one week
- Not fluent in English
- Those who are pregnant or planning on becoming pregnant during the duration of the study
- Unwilling to comply with study protocol
- People with cardiac implants
The study team makes the final eligibility decision.
Where it is enrolling
- Buffalo, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Buffalo, New York, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.